Peer Review History
| Original SubmissionMarch 5, 2021 |
|---|
|
PONE-D-21-07363 Workplace discrimination as risk factor for long-term sickness absence: Longitudinal analyses of onset and changes in workplace adversity PLOS ONE Dear Dr. Stenholm, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jun 14 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Ali B. Mahmoud, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information. Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the “Ethics Statement” field of the submission form (via “Edit Submission”). For additional information about PLOS ONE ethical requirements for human subjects research, please refer to http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research. 3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 4. Please amend the manuscript submission data (via Edit Submission) to include author Tianwei Xu. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: Yes Reviewer #3: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thanks for the opportunity to review this paper. I have several queries/clarifications set out below. Methods Overall I found the methods and results sections very difficult to read. Many of your paragraphs explaining your methods were just not clear. The problem is compounded possibly because of your use of run on sentences - sentences which run to 5/6/7 lines - and which become increasingly incomprehensible the longer they are. You could try splitting these long sentences into shorter sentences which might improve comprehension. See for example lines 332-337. Line 126 - you suddenly start discussing number of observations instead of number of participants - and this is displayed in some of your tables. Why have you done this - I could see no explanation provided in your manuscript? Line 139 - has the workplace discrimination question been used/validated elsewhere? What type of discrimination is it measuring? Paragraph commencing line 155 is not clear - perhaps you can show this in a diagram? And how do you know your participants didn't experience discrimination in year 0 - was this because the data wasn't collected? Similarly the paragraph commencing on line 169 is unclear. Line 172 - what was your cut off for psychological distress using the GHQ? Ditto the TAI? Results Line 274. These sentences are not clear - they don't seem to relate to figure 1 - which has more than you are describing in this paragraph - and appears to be set out differently to your depiction? Reviewer #2: Thank you for the opportunity to review the work entitled “Workplace discrimination as risk factor for long-term sickness absence: Longitudinal analyses of onset and changes in workplace adversity” This paper focuses on a relevant and important topic. In particular, I appreciate the aim to examine the onset of workplace discrimination (WD) and changes of WD on long-term sickness absence (LTSA). I think the methods are convincing. However, the paper has some areas for improvement and clarification. Please see my comments below. 1.The Introduction is well written. The authors have emphasized the lack of longitudinal studies on this topic and the methodological issues of previous studies, however, I believe that the authors need to explain more the rationale behind the study in the introduction section. In the introduction, it’s unclear how workplace discrimination is different from other working environment factors, such as job stress, job demand, or job support. Why workplace discrimination is a practical factor that the authors want to look at? In the discussion, the authors mentioned that workplace discrimination is an uncontrollable social stressor triggering stress reactions, but this ‘social stressor’ theory was not mentioned in the Introduction. Also, I think the introduction can benefit from explaining why focusing on LTSA? What is the government policy for LTSA in Finland, and whether the policy for LTSA is the same for those working in the public sector and those who work in other sectors? 2. Table 1 needs some clarification. For example, the authors said the study population is N=32519, but this number is not shown in Table 1. Also, as described “Of the 29597 participants who were not discriminated at baseline (39,413 employee-observations), 5.0% reported WD at the second time-point.” But this information is not clearly presented in Table 1. Reviewer #3: Thank you for the opportunity to review this interesting manuscript. Overall the details were presented coherently to approach the aim of the proposed study. I have a few minor comments for the authors to consider: • Abstract: o Please clarify if the RR or OR (line 48, line 51) were adjusted or crude ones. It would be good to clarify so by adding ‘adjusted’ or ‘crude’ to the RR or OR. • Introduction: o It would be good to clarify the setting of the study, e.g. Finnish evidence around this research topic is lacking, to link the research gap to the research aim. This clarification could be added to the beginning of the last paragraph (line 90), to set the scope of this study so that the readers are not expected worldwide data. • Methods: o Line 132: The authors mentioned that “observations with missing information on time-varying covariates (n=1125) were excluded”. Please justify a reason to not perform analyses using the “missing by random” (or other) technique. o Line 175: The authors mentioned that “directed acyclic graphs” method was used to identify potential confounders. Please include another supplementary graph of the DAG. o Sensitivity analyses (line 221 onwards): This may be renamed as ‘subgroup analyses’ or ‘supplementary analyses’. In saying that, it would be good to have a sensitivity analyses done on the full dataset and on the missing data dataset (or simulated for the missing variables) to assure the readers if there is any difference in the finding. o Please clarify if the level of significance was set at 5% (or 1% or lower due to the multiple comparisons). • Results: o It would be good to also specify the analyses done (e.g. logistic regression) in the footnotes of the tables (e.g., added to footnote c of Table 2, footnote a of Table 3, etc) o Sensitivity analyses (line 343 onwards): please update as per suggestions under the Methods section. o Figure 1: Please add analyses done as a footnote too. • Discussion o The limitations of the study may be grouped into a long paragraph, after the paragraph around the strengths of the study. o The last sentence in the Discussion section (line 445-446: “With our longitudinal study design, we were able to minimize reverse causality as a source of bias.”) could be placed elsewhere (e.g. in line 397) so that the ‘strengths’ of the study go together in a paragraph. o It would be good to add a sentence around the implication of this research finding (or a few sentences around suggestions for future studies) as the concluding remark. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Workplace discrimination as risk factor for long-term sickness absence: Longitudinal analyses of onset and changes in workplace adversity PONE-D-21-07363R1 Dear Dr. Stenholm, I'm pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Ali B. Mahmoud, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: all my earlier comments were addressed appropriately.......................................................... Reviewer #2: The manuscript has been thoroughly revised and my concerns and suggestions have been addressed. In particular, the introduction and method sections are now much clearer. Reviewer #3: Thank you for addressing my previous comments and improving the quality of this revised manuscript. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No |
| Formally Accepted |
|
PONE-D-21-07363R1 Workplace discrimination as risk factor for long-term sickness absence: Longitudinal analyses of onset and changes in workplace adversity Dear Dr. Stenholm: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Ali B. Mahmoud Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .